According to iTeos Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.79. In 2022 the company made an earnings per share (EPS) of $2.73 a decrease over its 2021 EPS that were of $6.10.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.79 | -128.94% |
2022 | $2.73 | -55.25% |
2021 | $6.10 | -524.78% |
2020 | -$1.44 | -46.35% |
2019 | -$2.68 |